BACKGROUND: Because of the risk of performing renal biopsies in children with co-morbid conditions, we carried out this study to identify candidate protein biomarkers in the urine of HIV-infected children with renal disease. DESIGN, SETTING, PARTICIPANTS & MEASUREMENTS: Urine samples from HIV-infected children with biopsy proven HIV-nephropathy (HIVAN; n = 4), HIV-associated Hemolytic Uremic Syndrome (HIV-HUS; n = 2), or no renal disease (n = 3) were analyzed by two-dimensional electrophoresis (2-DE) and proteomic methods. Positive findings were confirmed in HIV-infected children with (n = 20) and without (n = 10) proteinuria using commercially available assays. RESULTS: By 2-DE analysis, a single urine marker was not sufficient to distinguish children with HIVAN from the others. High urine levels of beta(2)-microglobulin and retinol-binding protein (RBP) suggested the presence of tubular injury. In addition, we found elevated urine levels of iron and the iron-related proteins, transferrin, hemopexin, haptoglobin, lactoferrin, and neutrophil gelatinase-associated lipocalin (NGAL), in children with HIVAN and HIV-HUS. Furthermore, we detected a significant accumulation of iron in the urine and kidneys of HIV-transgenic (Tg) rats with renal disease. CONCLUSION: These findings suggest that iron and iron-related proteins might be promising candidate urine biomarkers to identify HIV-infected children at risk of developing HIVAN and HIV-HUS. Moreover, based on the results of previous studies, we speculate that the release or accumulation of iron in the kidney of HIV-infected children may contribute to the rapid progression of their renal disease, and could become a new therapeutic target against HIVAN and HIV-HUS.
BACKGROUND: Because of the risk of performing renal biopsies in children with co-morbid conditions, we carried out this study to identify candidate protein biomarkers in the urine of HIV-infectedchildren with renal disease. DESIGN, SETTING, PARTICIPANTS & MEASUREMENTS: Urine samples from HIV-infectedchildren with biopsy proven HIV-nephropathy (HIVAN; n = 4), HIV-associated Hemolytic Uremic Syndrome (HIV-HUS; n = 2), or no renal disease (n = 3) were analyzed by two-dimensional electrophoresis (2-DE) and proteomic methods. Positive findings were confirmed in HIV-infectedchildren with (n = 20) and without (n = 10) proteinuria using commercially available assays. RESULTS: By 2-DE analysis, a single urine marker was not sufficient to distinguish children with HIVAN from the others. High urine levels of beta(2)-microglobulin and retinol-binding protein (RBP) suggested the presence of tubular injury. In addition, we found elevated urine levels of iron and the iron-related proteins, transferrin, hemopexin, haptoglobin, lactoferrin, and neutrophil gelatinase-associated lipocalin (NGAL), in children with HIVAN and HIV-HUS. Furthermore, we detected a significant accumulation of iron in the urine and kidneys of HIV-transgenic (Tg) rats with renal disease. CONCLUSION: These findings suggest that iron and iron-related proteins might be promising candidate urine biomarkers to identify HIV-infectedchildren at risk of developing HIVAN and HIV-HUS. Moreover, based on the results of previous studies, we speculate that the release or accumulation of iron in the kidney of HIV-infectedchildren may contribute to the rapid progression of their renal disease, and could become a new therapeutic target against HIVAN and HIV-HUS.
Authors: Adeline Vanderver; Raphael Schiffmann; Margaret Timmons; Katherine A Kellersberger; Dan Fabris; Eric P Hoffman; Jelena Maletkovic; Yetrib Hathout Journal: Clin Chem Date: 2005-09-09 Impact factor: 8.327
Authors: Sharmila Fagoonee; Jakub Gburek; Emilio Hirsch; Samuele Marro; Soren K Moestrup; Jacob M Laurberg; Erik I Christensen; Lorenzo Silengo; Fiorella Altruda; Emanuela Tolosano Journal: Am J Pathol Date: 2005-04 Impact factor: 4.307
Authors: Paturi V Rao; Xinfang Lu; Melissa Standley; Patrick Pattee; Gundupalle Neelima; Gudige Girisesh; K V Dakshinamurthy; Charles T Roberts; Srinivasa R Nagalla Journal: Diabetes Care Date: 2007-03 Impact factor: 19.112
Authors: Patricio E Ray; Xue-Hui Liu; Louis R Robinson; William Reid; Lian Xu; Jennie W Owens; Odell D Jones; Frank Denaro; Harry G Davis; Joseph L Bryant Journal: Kidney Int Date: 2003-06 Impact factor: 10.612
Authors: Parnell C Mattison; Angel A Soler-García; Jharna R Das; Marina Jerebtsova; Sofia Perazzo; Pingtao Tang; Patricio E Ray Journal: Pediatr Nephrol Date: 2011-09-30 Impact factor: 3.714
Authors: Julie Ho; Martina Reslerova; Brent Gali; Ang Gao; Jennifer Bestland; David N Rush; Peter W Nickerson; Claudio Rigatto Journal: Clin J Am Soc Nephrol Date: 2011-09-01 Impact factor: 8.237
Authors: David A Sola-Del Valle; Sumit Mohan; Jen-Tse Cheng; Neal A Paragas; Meghan E Sise; Vivette D D'Agati; Jonathan Barasch Journal: Nephrol Dial Transplant Date: 2011-05-09 Impact factor: 5.992
Authors: Sofia Perazzo; Ángel A Soler-García; Yetrib Hathout; Jharna R Das; Patricio E Ray Journal: Proteomics Clin Appl Date: 2015-06 Impact factor: 3.494